These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10667567)

  • 21. [The cyclin A, B1, D1 and E expression in advanced non-small cell lung cancer--stages IIIB-IV (preliminary report)].
    Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Jankowska R
    Pol Merkur Lekarski; 2011 Apr; 30(178):253-8. PubMed ID: 21595169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F; Dosaka-Akita H; Mishina T; Nishi M; Kojima T; Hiroumi H; Ogura S; Shimizu M; Katoh H; Kawakami Y
    Clin Cancer Res; 2000 Oct; 6(10):4073-81. PubMed ID: 11051259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of cyclin D1 but not of cyclin E is an indicator of poor prognosis in small adenocarcinomas of the lung.
    Ikehara M; Oshita F; Ito H; Ohgane N; Suzuki R; Saito H; Yamada K; Noda K; Mitsuda A; Kameda Y
    Oncol Rep; 2003; 10(1):137-9. PubMed ID: 12469159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
    Ishida T; Kaneko S; Akazawa K; Tateishi M; Sugio K; Sugimachi K
    Cancer Res; 1993 Oct; 53(20):5000-3. PubMed ID: 8104690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors in resected satellite-nodule T4 non-small cell lung cancer.
    Rao J; Sayeed RA; Tomaszek S; Fischer S; Keshavjee S; Darling GE
    Ann Thorac Surg; 2007 Sep; 84(3):934-8; discussion 939. PubMed ID: 17720402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.
    Burke L; Flieder DB; Guinee DG; Brambilla E; Freedman AN; Bennett WP; Jones RT; Borkowski A; Caporaso NA; Fleming M; Trastek V; Pairolero P; Tazelaar H; Midthun D; Jett JR; Liotta LA; Travis WD; Harris CC
    Clin Cancer Res; 2005 Jan; 11(1):232-41. PubMed ID: 15671551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complications and outcomes after pulmonary resection for cancer in patients 80 to 89 years of age.
    Matsuoka H; Okada M; Sakamoto T; Tsubota N
    Eur J Cardiothorac Surg; 2005 Sep; 28(3):380-3. PubMed ID: 16054820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
    Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
    Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of p27KIP1 expression in resected non-small cell lung cancers: analysis in combination with expressions of p16INK4A, pRB, and p53.
    Hirabayashi H; Ohta M; Tanaka H; Sakaguchi M; Fujii Y; Miyoshi S; Matsuda H
    J Surg Oncol; 2002 Dec; 81(4):177-84; discussion 184. PubMed ID: 12451621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
    Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
    Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of blood group antigen A by stage I non-small cell lung carcinomas.
    Rice TW; Tubbs RR; Hoeltge GA; Kirby TJ; Meeker DP; Medendorp SV; Bukowski RM
    Ann Thorac Surg; 1995 Mar; 59(3):568-72. PubMed ID: 7887691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.
    Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M
    J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer.
    Fernando HC; Santos RS; Benfield JR; Grannis FW; Keenan RJ; Luketich JD; Close JM; Landreneau RJ
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):261-7. PubMed ID: 15678034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of pleural lavage cytology for non-small cell lung cancer: is surgical resection valid for patients with positive pleural lavage cytology?
    Kawachi R; Nakazato Y; Masui K; Takei H; Koshi-ishi Y; Goya T
    Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):265-8. PubMed ID: 19429636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Survival and prognostic factors of non small cell lung cancer: analytic review of 211 cases].
    Battikh MH; Ben Sayah MM; Joobeur S; Rouetbi N; Ben Salem K; Daami M; Maatallah A; Raham W; Farhat C; El Kamel A
    Tunis Med; 2004 Sep; 82(9):843-8. PubMed ID: 15693478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of glutathione S-transferase pi and glutathione synthase correlates with survival in early stage non-small cell carcinomas of the lung.
    Allen TC; Granville LA; Cagle PT; Haque A; Zander DS; Barrios R
    Hum Pathol; 2007 Feb; 38(2):220-7. PubMed ID: 17234469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical implication of cyclin B1 in non-small cell lung cancer.
    Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Kimura Y; Uchida Y
    Oncol Rep; 2003; 10(5):1381-6. PubMed ID: 12883711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.